Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
vaccine manufacturer |
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
1989
|
| gptkbp:affiliatedWith |
gptkb:University_of_Toronto
|
| gptkbp:ceased_operations |
1989
|
| gptkbp:contributedTo |
development of Salk polio vaccine
mass production of insulin |
| gptkbp:country |
gptkb:Canada
|
| gptkbp:foundedIn |
1914
|
| gptkbp:founder |
gptkb:John_Gerald_FitzGerald
|
| https://www.w3.org/2000/01/rdf-schema#label |
Connaught Laboratories
|
| gptkbp:location |
gptkb:Toronto
|
| gptkbp:notableEmployee |
gptkb:Frederick_Banting
gptkb:Charles_Best |
| gptkbp:notableProduct |
gptkb:insulin
polio vaccine diphtheria antitoxin tetanus antitoxin |
| gptkbp:originalName |
gptkb:Antitoxin_Laboratory
|
| gptkbp:renamed |
gptkb:Connaught_Medical_Research_Laboratories
|
| gptkbp:successor |
gptkb:Sanofi_Pasteur_Limited
|
| gptkbp:bfsParent |
gptkb:Sanofi_Pasteur
|
| gptkbp:bfsLayer |
5
|